Dublin – Research and Markets has announced the addition of the “The Top 100 Developers of Cancer In-Vitro Diagnostics Tests” report to their offering.
This unique and comprehensive report identifies and profiles the leading 100 developers of cancer in-vitro diagnostics tests.
Report Target Market:
1) In-Vitro Diagnostics Companies
Usage: competitive/financial analysis and strategic partner/alliance identification.
The Top 100 Developers Of Cancer In-Vitro Diagnostics Tests’ is perfect for suppliers of raw materials, technology and services to identify top potential customers.
This report is ideal for distributors of in-vitro diagnostics instruments and tests to identify the leading manufacturers with the best products.
4) Industry Associations:
The Top 100 Developers Of Cancer In-Vitro Diagnostics Tests’ is a useful reference tool for in-vitro diagnostic associations.
Note: Most people will be aware of some of the major developers of cancer in-vitro diagnostics tests such as Accugenomics, Inc., Agendia Inc., Biocept, Inc., GeneNews Limited and OvaGene Oncology, Inc. but this major new report looks at all 100 of the top companies.
Report data field structure is as follows:
– Company Name
– Year Established
– Number of Employees
– Key Executives
– Company Description
– Clinical Specialties
– Revenue ($U.S. million)
– Location Status
– Stock Exchange/Ticker Symbol
– Parent Company
For more information about this report visit https://www.researchandmarkets.com/research/8rh3l9/the_top_100